Omnicell has deleveraged sharply, with total debt falling from $615.4M in 2024Q2 to $189.7M in 2026Q3 and cash rising to $314.9M, which suggests the balance sheet has moved from a leveraged profile toward net cash.
Price trend, volume and key moving averages
Trailing total returns as of 11/8/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q4 2026Latest Oct 29, 2026 | $0.58+38.9% vs $0.42 | $308M+1.1% vs $304M |
Q3 2026 Jul 30, 2026 | $0.94+101.1% vs $0.47 | $312M+0.6% vs $310M |
Q2 2026 Apr 28, 2026 | $0.55+66.7% vs $0.33 | $310M+1.9% vs $304M |
Q1 2026 Feb 5, 2026 | $0.40-14.9% vs $0.47 | $314M+0.2% vs $313M |
While the top- and bottom-line numbers for Omnicell (OMCL) give a sense of how the business performed in the quarter ended September 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Omnicell (OMCL) came out with quarterly earnings of $0.58 per share, beating the Zacks Consensus Estimate of $0.42 per share. This compares to earnings of $0.51 per share a year ago.
FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell Announces Third Quarter 2026 Financial Results.
OMCL raises its 2026 earnings outlook on cost discipline and efficiency, but rising memory costs and delayed Titan XT adoption pose challenges.
Benchmark OMCL against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Omnicell, Inc. (OMCL)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $37.34 | $1.7B | 38.85 | 6.53% | 3.59% | 3.5% | — | |
| $211.88 | $58.38B | 50.76 | -10.91% | 5.66% | 3.67% | 1.96% | |
| $86.05 | $9.8B | 23.00 | 4.03% | 3.07% | 8.83% | — | |
| $1060.84 | $123.8B | 26.34 | 12.36% | 1.12% | — | 0.29% | |
| $271.72 | $63.64B | 34.82 | 14.23% | 0.71% | — | 0.76% | |
| $303.73 | $49.34B | 49.40 | 16.34% | 29.34% | 14% | — |
Omnicell, Inc. (OMCL) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
Omnicell, Inc. (OMCL) SEC filings — annual & quarterly reports (10-K, 10-Q)
Oct 29, 2026·SEC
Jul 30, 2026·SEC
Jul 1, 2026·SEC
Get notified when OMCL posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Omnicell, Inc. (OMCL) stock FAQ — growth, dividends, profitability & financials explained
Omnicell, Inc. (OMCL) reported $1.24B in revenue over the trailing twelve months. Revenue was $1.18B in fiscal year 2025. That is 1659% more than the $67.4M of fiscal year 2000.
Omnicell, Inc. (OMCL) grew revenue by 5.6% over the trailing twelve months, compared with the twelve months before.
Yes. Omnicell, Inc. (OMCL) earned $44.7M in net income over the trailing twelve months (a 3.6% net margin).
Omnicell, Inc. (OMCL) had a return on equity (ROE) of 3.5% over the trailing twelve months. That is below the market's typical 10-15%.
Omnicell, Inc. (OMCL) generated $144.6M in free cash flow over the trailing twelve months.
